Updates

Mpac Group - Resilient performance for FY21

February 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Ahead of results on 14 March, Mpac, the high speed packaging and automations solutions provider, said FY21 had ended well with pretax profit in-line despite the operational challenges caused by the global supply chain crisis and the impact on labour availability due to Covid-19. Mpac has made good progress on the development of the clean energy casting and unit cell assembly line on the FREYR Battery contract, won in July 2021. The project remains on track to be completed in Q3 22. Overall the group ended 2021 with a closing order book of c.£77m, +39% year-on-year and providing good coverage of FY22 forecast revenue. For the year already ended 31 December, Shore Cap forecasts pretax profit of £8.2m/eps 32.2p with £8.8m/34.5p for t ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Superdry - Eps of 20p and 38p forecast for next two years

Xaar - Surprise profit in H2 21

Mpac (June 2024)

MPAC - Plans to double sales within five years (May 2024)

MPAC (April 2024)

Mpac (February 2024)

MPAC (August 2023)

Mpac (April 2023)

Mpac Group - Clean energy opportunity (February 2023)

Mpac (August 2022)

Mpac - Order intake in year >£100m (April 2022)

MPAC - Lollies driving sales of packaging equipment in US (October 2021)

Mpac (August 2021)

Mpac (May 2021)

Mpac - Trading ahead of forecast (February 2021)

Mpac Group - Enters fast growing craft beer packaging market (October 2020)

Mpac - Noticeable resilience in healthcare sector (August 2020)

Mpac (April 2020)

Mpac - Meeting notes (March 2020)

Mpac - Five profit upgrades in FY19 (February 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X